“Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor”. 2019. Journal of Regulatory Science 7 (February): 1-9. https://doi.org/10.21423/JRS-V07SHIBATA.